These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36012465)

  • 1. Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms.
    Berger M; Naseem KM
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation.
    Berger M; Wraith K; Woodward C; Aburima A; Raslan Z; Hindle MS; Moellmann J; Febbraio M; Naseem KM
    Platelets; 2019; 30(4):467-472. PubMed ID: 29733744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of platelet function by class B scavenger receptors in hyperlipidemia.
    Zimman A; Podrez EA
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2350-6. PubMed ID: 21071700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein as a modulator of platelet and coagulation responses.
    van der Stoep M; Korporaal SJ; Van Eck M
    Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scavenger receptor A and CD36 are implicated in mediating platelet activation induced by oxidized low- density lipoproteins.
    Collot-Teixeira S; De Lorenzo F; McGregor JL
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2491-2. PubMed ID: 18029908
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-density lipoprotein and its effect on human blood platelets.
    Relou IA; Hackeng CM; Akkerman JW; Malle E
    Cell Mol Life Sci; 2003 May; 60(5):961-71. PubMed ID: 12827283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.
    Biswas S; Zimman A; Gao D; Byzova TV; Podrez EA
    Circ Res; 2017 Sep; 121(8):951-962. PubMed ID: 28775078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative modification of low-density lipoproteins in atherothrombosis.
    Holvoet P
    Acta Cardiol; 1998; 53(5):253-60. PubMed ID: 9922802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players.
    Koller E; Volf I; Gurvitz A; Koller F
    Pathophysiol Haemost Thromb; 2006; 35(3-4):322-45. PubMed ID: 16877881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
    Siegel-Axel D; Daub K; Seizer P; Lindemann S; Gawaz M
    Cardiovasc Res; 2008 Apr; 78(1):8-17. PubMed ID: 18218686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
    Aviram M
    Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
    Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
    Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
    Siess W
    Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
    Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
    Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1.
    Kakutani M; Masaki T; Sawamura T
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):360-4. PubMed ID: 10618423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of CD36/GPIV in Platelet Biology.
    Bendas G; Schlesinger M
    Semin Thromb Hemost; 2024 Mar; 50(2):224-235. PubMed ID: 37192651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.
    Valiyaveettil M; Kar N; Ashraf MZ; Byzova TV; Febbraio M; Podrez EA
    Blood; 2008 Feb; 111(4):1962-71. PubMed ID: 17993610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
    Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-protein particles secreted from activated platelets reduce macrophage uptake of low density lipoprotein.
    Fuhrman B; Brook GJ; Aviram M
    Atherosclerosis; 1991 Aug; 89(2-3):163-73. PubMed ID: 1793444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo.
    Holy EW; Akhmedov A; Speer T; Camici GG; Zewinger S; Bonetti N; Beer JH; Lüscher TF; Tanner FC
    J Am Coll Cardiol; 2016 Oct; 68(15):1664-1676. PubMed ID: 27712780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.